# Anagram Therapeutics

**Source:** https://www.startuphub.ai/startups/anagram-therapeutics
**Profile type:** Startup

> Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

## About

Anagram Therapeutics is a clinical-stage private biopharmaceutical company focused on improving the lives of individuals suffering from exocrine pancreatic insufficiency (EPI) caused by conditions such as cystic fibrosis, pancreatic cancer, and other related disorders. The company is developing ANG003, an orally delivered recombinant enzyme therapy.

## Key facts

- **Slug:** anagram-therapeutics
- **Website:** https://anagramtx.com
- **Location:** Natick, Massachusetts, USA
- **Founded:** 2017-01-01
- **Operating status:** Active
- **Total funding:** $285M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials, Enzyme Therapeutics, Malabsorption Syndromes, Exocrine Pancreatic Insufficiency, Cystic Fibrosis, Rare Diseases, Nutrient Metabolism Disorders, Enzyme Replacement Therapy
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/anagram-therapeutics/
  - Twitter: https://twitter.com/anagramtx

## Frequently asked

### What does Anagram Therapeutics do?

Anagram Therapeutics is a clinical-stage private biopharmaceutical company focused on improving the lives of individuals suffering from exocrine pancreatic insufficiency (EPI) caused by conditions such as cystic fibrosis, pancreatic cancer, and other related disorders. The company is developing ANG003, an orally delivered recombinant enzyme therapy.

### What is Anagram Therapeutics's revenue?

StartupHub estimates Anagram Therapeutics's annual revenue at $44.8M (range $14.9M to $126.5M, 34% confidence), based on comparable companies in the sector.

### What is Anagram Therapeutics's valuation?

StartupHub estimates Anagram Therapeutics's effective valuation at $1.1B (range $712.5M to $1.7B, 24% confidence), based on comparable companies in the sector.

### How much funding has Anagram Therapeutics raised?

Anagram Therapeutics has raised a total of $285M in funding. The most recent round on record is Investment.

### Where is Anagram Therapeutics headquartered?

Anagram Therapeutics is headquartered in Natick, Massachusetts, USA.

### When was Anagram Therapeutics founded?

Anagram Therapeutics was founded in 2017.

### What industry does Anagram Therapeutics operate in?

Anagram Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Anagram Therapeutics",
          "item": "https://www.startuphub.ai/startups/anagram-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/anagram-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/anagram-therapeutics",
      "name": "Anagram Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Anagram Therapeutics. Anagram Therapeutics is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency. Headquartered in Natick, Massachusetts, USA.",
      "dateModified": "2026-05-08T06:00:19.357+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/anagram-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/anagram-therapeutics#organization",
      "name": "Anagram Therapeutics",
      "url": "https://anagramtx.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/14562ee0-5525-41d0-bede-9e9037364282-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/14562ee0-5525-41d0-bede-9e9037364282-square.webp",
      "description": "This is the official profile of Anagram Therapeutics. Anagram Therapeutics is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency. Headquartered in Natick, Massachusetts, USA.",
      "sameAs": [
        "https://www.linkedin.com/company/anagram-therapeutics/",
        "https://twitter.com/anagramtx",
        "https://www.startuphub.ai/startups/anagram-therapeutics"
      ],
      "foundingDate": "2017-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Natick",
        "addressRegion": "Massachusetts",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare",
        "Biotech",
        "Drug Discovery",
        "Clinical Trials",
        "Enzyme Therapeutics",
        "Malabsorption Syndromes",
        "Exocrine Pancreatic Insufficiency",
        "Cystic Fibrosis",
        "Rare Diseases",
        "Nutrient Metabolism Disorders",
        "Enzyme Replacement Therapy"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/anagram-therapeutics#profile-assessment",
      "name": "Anagram Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/anagram-therapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/14562ee0-5525-41d0-bede-9e9037364282-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of Anagram Therapeutics. Anagram Therapeutics is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency. Headquartered in Natick, Massachusetts, USA. Agent Readiness score: 23/100. Full audit: https://www.startuphub.ai/startups/anagram-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Anagram Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-08",
        "name": "Anagram Therapeutics - Profile Score 55/100",
        "reviewBody": "This is the official profile of Anagram Therapeutics. Anagram Therapeutics is a startup founded in 2017, operating in Biotechnology and Pharmaceuticals. Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency. Headquartered in Natick, Massachusetts, USA. Agent Readiness score: 23/100. Full audit: https://www.startuphub.ai/startups/anagram-therapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 55,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```